PSMD1 and COVID-19: Unexpectedly, the subgroup B of anti-SARS-CoV-2-S1 RBD-positive respondents had no COVID-19 resistance compared with that of the anti-SARS-CoV-2-S1 RBD-negative (D) and not vaccinated (C) subgroups (p > 0.05; Log rank test).